Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

HGPRT in the Gilles de la Tourette syndrome.

Johnson GG, Pepple JM, Singer HS, Littlefield JW.

N Engl J Med. 1977 Aug 11;297(6):339. No abstract available.

PMID:
267247
2.

Hypoxanthine guanine phosphoribosyltransferase (HGPRT) in Gilles de la Tourette syndrome.

Merril CR, Leavitt J, Van Keuren ML, Ebert MH, Caine ED.

Neurology. 1979 Jan;29(1):131-4.

PMID:
284202
3.

Purine phosphoribosyltransferase in gilles de la Tourette syndrome.

Van Woert MH, Yip LC, Balis ME.

N Engl J Med. 1977 Jan 27;296(4):210-2. No abstract available.

PMID:
299777
4.

Gilles de la Tourette syndrome: further studies and thoughts.

Singer HS, Pepple JM, Ramage AL, Butler IJ.

Ann Neurol. 1978 Jul;4(1):21-5.

PMID:
279303
5.

The Gilles de la Tourette syndrome: a principal component factor analytic study of a large pedigree.

Robertson MM, Cavanna AE.

Psychiatr Genet. 2007 Jun;17(3):143-52.

PMID:
17417057
6.

Atypical Gilles de la Tourette Syndrome with beta-mannosidase deficiency.

Sedel F, Friderici K, Nummy K, Caillaud C, Chabli A, Dürr A, Lubetzki C, Agid Y.

Arch Neurol. 2006 Jan;63(1):129-31.

PMID:
16401745
7.

Gilles de la Tourette syndrome is not linked to D2-dopamine receptor.

Gelernter J, Pakstis AJ, Pauls DL, Kurlan R, Gancher ST, Civelli O, Grandy D, Kidd KK.

Arch Gen Psychiatry. 1990 Nov;47(11):1073-7.

PMID:
1978653
8.

CSF cholinesterase activity in Gilles de la Tourette's syndrome.

Singer HS, Oshida L, Coyle JT.

Arch Neurol. 1984 Jul;41(7):756-7.

PMID:
6588929
9.

Gilles de la Tourette syndrome in Papua New Guinea.

Johnson FY.

P N G Med J. 1995 Jun;38(2):127-32.

PMID:
9599974
10.
11.
12.

S100B protein, glia and Gilles de la Tourette syndrome.

van Passel R, Schlooz WA, Lamers KJ, Lemmens WA, Rotteveel JJ.

Eur J Paediatr Neurol. 2001;5(1):15-9.

PMID:
11277359
13.
14.
15.

Altered modulation of intracortical excitability during movement preparation in Gilles de la Tourette syndrome.

Heise KF, Steven B, Liuzzi G, Thomalla G, Jonas M, Müller-Vahl K, Sauseng P, Münchau A, Gerloff C, Hummel FC.

Brain. 2010 Feb;133(Pt 2):580-90. doi: 10.1093/brain/awp299.

PMID:
20008030
16.

Oculomotor control in Gilles de la Tourette syndrome.

Bollen EL, Roos RA, Cohen AP, Minderaa RB, Reulen JP, Van de Wetering BJ, Van Woerkom TC, Buruma OJ.

J Neurol Neurosurg Psychiatry. 1988 Aug;51(8):1081-3.

17.

No evidence for genetic linkage of Gilles de la Tourette syndrome on chromosomes 7 and 18.

Heutink P, van de Wetering BJ, Breedveld GJ, Weber J, Sandkuyl LA, Devor EJ, Heiberg A, Niermeijer MF, Oostra BA.

J Med Genet. 1990 Jul;27(7):433-6.

18.

[Neuropsychological findings in children with Gilles de la Tourette syndrome].

Lanser JB, Velders G, Jennekens-Schinkel A, Roos RA.

Ned Tijdschr Geneeskd. 1989 Dec 16;133(50):2515-7. Dutch.

PMID:
2594124
19.

Monoamine oxidase and catechol-O-methyltransferase activities in cultured fibroblasts and blood cells from children with autism and the Gilles de la Tourette syndrome.

Giller EL Jr, Young JG, Breakefield XO, Carbonari C, Braverman M, Cohen DJ.

Psychiatry Res. 1980 May;2(2):187-97.

PMID:
6932062
20.

Familial pattern of Gilles de la Tourette syndrome.

Kidd KK, Prusoff BA, Cohen DJ.

Arch Gen Psychiatry. 1980 Dec;37(12):1336-9.

PMID:
6934712
Items per page

Supplemental Content

Support Center